Mesoblast (MESO) Operating Expenses (2014 - 2023)

Mesoblast has reported Operating Expenses for 10 years, with the latest figure at $73.3 million in Q2 2023.

• Quarterly Operating Expenses rose 20.99% year-over-year to $73.3 million in Q2 2023, while the trailing twelve-month figure through Dec 2024 was $73.3 million (up 25.18% YoY) and the FY2025 annual result came in at $74.1 million, up 14.56% from the prior year.
• Operating Expenses rose to $73.3 million in Q2 2023 per MESO's latest filing, from -$7.1 million in the prior quarter.
• Over five years, Operating Expenses peaked at $99.0 million in Q2 2021 and troughed at -$19.3 million in Q3 2020.
• A 5-year average of $9.4 million and a median of -$9.8 million in 2021 frame the typical range for Operating Expenses.
• The widest YoY moves for Operating Expenses: up 949.23% in 2020, down 55.61% in 2020.
• Over 5 years, Operating Expenses stood at -$14.2 million in 2019, then slipped by 0.59% to -$14.2 million in 2020, then advanced by 28.37% to -$10.2 million in 2021, then climbed by 24.66% to -$7.7 million in 2022, then surged by 1054.21% to $73.3 million in 2023.
• According to Business Quant data, Operating Expenses over the past three periods registered $73.3 million, -$7.1 million, and -$7.7 million for Q2 2023, Q1 2023, and Q4 2022 respectively.